SCOTUS Sets Dates for Key Pharma Cases

The Supreme Court has set dates to hear two key cases affecting the generic drug industry. On March 19, the court will hear Mutual v. Bartlett, a case centering on generic drug preemption issues. On March 25, the court will hear Federal Trade Commission v. Watson Pharmaceuticals, which focuses on reverse patent settlement agreements.
Generic Line